Cabaletta Bio is trading 5.1% down at $1.60, amid broader market pressure following September CPI above forecast.
- September CPI was 3.7% year over year, above the 3.6% forecast, reviving concerns about Federal Reserve rate policy. Reuters reported U.S. stock futures fell after the data.
- XBI was down 2.01% during the regular session. No clear company-specific announcement explaining the October 14 decline has surfaced; the latest company release found was an October 5 inducement-grant notice.